Meet the Team

Prior to joining Imbio, Mr. Hannes was Vice President of Business Development for NeuWave Medical, a microwave ablation start-up based out of Madison, Wisconsin. Mr. Hannes joined NeuWave in its second year of commercial sales and was a key member of the leadership team which built the company into the market leader in microwave ablation, including gaining broad acceptance across the nation’s Top 50 cancer centers.

Mr. Hannes led NeuWave’s Business Development and Strategy, corporate contracting and Marketing during this rapid transition from start-up to growth business. Prior to Neuwave, Mr. Hannes spent more than 14 years at GE Healthcare across a variety of operational and commercial leadership positions including Corporate Purchasing, Commercial Operations, Finance, and Global Service P&L leadership. Early in his career, Mr. Hannes was a manager in Ford Motor’s Corporate Purchasing group where he built his global commercial, strategy and lean manufacturing/operations experience. Mr. Hannes has a B.S. in Business from The University of Dayton and an MBA from the University of Madison – Wisconsin.

Neal began his career in public accounting at Grant Thornton and holds a Bachelor of Arts degree from Gustavus Adolphus College. He is a Certified Public Accountant licensed in the state of Minnesota.

From 2005 to 2008, Mr. Cunagin served as the President of Micro Dynamics and Logic Product Development, a product engineering and manufacturing company with over 400 employees and sales in excess of $90 million. Prior to the merger with Micro Dynamics, he was CEO, Chairman and majority owner of Logic Product Development.

Under his guidance, Logic grew from startup into one of the largest fully integrated product development-consulting firms in the US with sales in excess of $45 million and more than 100 product development engineers located in several international locations. He is the author of two patents, was noted as one of “forty under 40” in 1999 by City Business and has a B.S.M.E. from the University of Kentucky. Away from work, Danny is an avid endurance athlete and a burgeoning yogi.

Dr. Hogarth received his medical degree at Case Western Reserve University School of Medicine in Cleveland, Ohio. He then completed a residency in Internal Medicine and a fellowship in Pulmonary and Critical Care at The University of Chicago. He has been published in the New England Journal of Medicine, Chest, ERJ and many other journals. He previously served on the editorial board of CHEST, where he was the section editor for the podcast section and giants in chest medicine series. He helped write the 2016 Alpha One Antitrypsin deficiency Clinical Practice Guidelines. He has won numerous clinical awards and teaching awards from his University. He is a founding member and the past President of the Society for Advanced Bronchoscopy.

The majority of cancer patients are treated in part with ionizing radiation and Dr. Rehemtulla is well known among clinical Radiation Oncology departments. He has been instrumental in the development of the voxel-based technology and is a co-inventor on the licensed patents from the University of Michigan. Dr. Rehemtulla has a 20-year history of developing products in the fields of cancer and cardiovascular disease. He trained at the Scripps Research Institute in La Jolla, where he developed technologies for diagnostic use in cardiovascular diseases. While at the Genetics Institute in Cambridge MA, he was involved in the development of protein therapeutics for Hemophilia A and B, both of which are in use clinically.